Logo

Cepheid

Cepheid, Oxford Nanopore to Broaden Use Case for Nanopore Sequencing in Infectious Disease Testing
Premium

The firms are developing a workflow that will include Cepheid's sample and library preparation, nanopore sequencing, and automated data analysis.

Oxford Nanopore Technologies, Cepheid Partner for Automated Pathogen Sequencing

The two firms aim to develop an end-to-end solution to simplify the nanopore sequencing workflow and eventually enable expanded clinical use.

Top Five Articles on GenomeWeb Last Week: MCED Test Debate, Eric Green Out as NHGRI Director, More

Last week, GenomeWeb's readers were most interested in the ongoing debate over multi-cancer early detection (MCED) tests.

Cepheid to Lay off 167 Employees

The employees are located in California's Alameda County, San Joaquin County, and Santa Clara County.

Danaher Prepares for Volume-Based Procurement, Respiratory Headwinds in Dx Biz in 2025
Premium

The firm's full-year 2024 revenues were essentially flat, with core revenues declining 2 percent.

Jan 14, 2025

Danaher CEO Outlines Financials and China Expectations at JP Morgan
Premium

Dec 6, 2024

Cepheid Tuberculosis Assay Receives WHO Prequalification

Oct 30, 2024

World Health Organization Adds Cepheid Mpox Tests to Emergency-Use List

Oct 18, 2024

Doctors Without Borders Urges Danaher, Cepheid to Further Reduce Price of TB Tests

Sep 25, 2024

Cepheid, Fleming Initiative Partner to Address Antimicrobial Resistance

Aug 23, 2024

New Mpox Emergency Sounds Alarm for Increased Development of Point-of-Care MDx Tests
Premium

Aug 6, 2024

Cepheid Lays off 626 Employees in Manufacturing Consolidation Move

Jul 17, 2024

Danaher Launches US, UK Laboratories for Precision Medicine Test Development

Jun 28, 2024

Cepheid Receives FDA Marketing Authorization for Point-of-Care Hepatitis C Test

Apr 3, 2024

Cepheid Awarded WHO Prequalification for Extended Coverage of Point-of-Care HIV Test

Mar 11, 2024

Cepheid Nabs FDA Clearance for Molecular Group B Strep Test

Jan 18, 2024

Cepheid Gains Expanded FDA Clearance With CLIA Waiver for Multiplex Vaginal Panel

Sep 19, 2023

Danaher Agrees to Provide Cepheid Tuberculosis Test to Global Fund at Cost

May 30, 2023

Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring

May 26, 2023

People in the News at Invitae, Cepheid, Nucleai, Angle, Quantum-Si, Twist Bioscience

Apr 25, 2023

Danaher Business Shifts as COVID-19 Revenues Continue to Decline
Premium

Apr 19, 2023

Cepheid Preparing New Infectious Disease Test Launches in 2023, Beyond
Premium

Mar 10, 2023

BioMérieux, Biocartis, Beckman Coulter Gain FDA 510(k) Clearances in February

Feb 13, 2023

Boston University, Cepheid Get FDA EUAs for COVID-19, Monkeypox Tests

Jan 24, 2023

Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China